J 2022

Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance

JESTER, Dylan J., Martin VYHNALEK, Ross ANDEL, Hana MARKOVA, Tomas NIKOLAI et. al.

Základní údaje

Originální název

Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance

Autoři

JESTER, Dylan J. (garant), Martin VYHNALEK (203 Česká republika), Ross ANDEL, Hana MARKOVA (203 Česká republika), Tomas NIKOLAI, Jan LACZO, Veronika MATUSKOVA (203 Česká republika), Katerina CECHOVA (203 Česká republika), Kateřina SHEARDOVÁ (203 Česká republika, domácí) a Jakub HORT (203 Česká republika)

Vydání

Journal of Alzheimers Disease, Amsterdam, IOS Press, 2022, 1387-2877

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30210 Clinical neurology

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.000

Kód RIV

RIV/00216224:14110/22:00128319

Organizační jednotka

Lékařská fakulta

UT WoS

000784452600020

Klíčová slova anglicky

Cognitive aging; immediate recall; subjective memory complaints; verbal memory

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 27. 1. 2023 11:13, Mgr. Tereza Miškechová

Anotace

V originále

Background: Older adults with subjective cognitive decline (SCD) are at an increased risk of progression to mild cognitive impairment (MCI) or dementia. However, few have examined the specific cognitive tests that are associated with progression. Objective: This study examined performance on 18 neuropsychological tests among participants with SCD who later progressed to MCI or dementia. Methods: We included 131 participants from the Czech Brain Aging Study that had SCD at baseline. They completed a comprehensive neuropsychological battery including cognitive tests from the Uniform Data Set 2.0 enriched by the verbal memory test Rey Auditory Verbal Learning Test (RAVLT) and Rey-Osterrieth Complex Figure Test (ROCFT). Results: Fifty-five participants progressed: 53% to non-amnestic MCI (naMCI), 44% to amnestic MCI (aMCI), and 4% to dementia. Scoring one SD below the mean at baseline on the RAVLT 1 and RAVLT 1-5 was associated with 133% (RAVLT 1; HR: 2.33 [1.50, 3.62]) and 122% (RAVLT 1-5; HR: 2.22 [1.55, 3.16]) greater risk of progression to MCI or dementia over 3.84 years on average. Worse performance on the RAVLT 5, RAVLT 1-5, RAVLT 30, and ROCFT-Recall was associated with progression to aMCI whereas worse performance on the RAVLT 1, TMT B, and Boston Naming Test was associated with progression to naMCI. Conclusion: At baseline, lower verbal memory performance was most strongly associated with progression to aMCI whereas lower executive or language performance was most strongly associated with progression to naMCI.